Annual report pursuant to Section 13 and 15(d)

Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)

v3.21.2
Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Balance $ 1,381,192    
Balance 1,562,971 $ 1,381,192  
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]      
Balance 0 0 $ 24,682
Other comprehensive income (loss) before reclassifications 0 [1] 0 0
Reclassification from loss on derivatives to interest expense, net of taxes [2] 0 0  
Balance 0 0 0
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] | Accounting Standards Update 2018-02 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]      
Balance     2,371
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] | Accounting Standards Update 2016-01 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]      
Balance     (27,053)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]      
Balance (83,946) (73,983) (69,496)
Other comprehensive income (loss) before reclassifications 32,848 [1] (9,963) (4,487)
Reclassification from loss on derivatives to interest expense, net of taxes [2] 0 0  
Balance (51,098) (83,946) (73,983)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member] | Accounting Standards Update 2018-02 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]      
Balance     0
Accumulated Foreign Currency Adjustment Attributable to Parent [Member] | Accounting Standards Update 2016-01 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]      
Balance     0
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member]      
Balance (13,253) (9,537) 0
Other comprehensive income (loss) before reclassifications 100 [1] (7,179) (9,537)
Reclassification from loss on derivatives to interest expense, net of taxes [2] 6,960 3,464  
Balance (6,193) (13,253) (9,537)
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member] | Accounting Standards Update 2018-02 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]      
Balance     0
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member] | Accounting Standards Update 2016-01 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]      
Balance     0
AOCI Attributable to Parent [Member]      
Balance (97,199) (83,521) (44,814)
Other comprehensive income (loss) before reclassifications 32,948 [1] (17,142) (14,024)
Reclassification from loss on derivatives to interest expense, net of taxes [2] 6,960 3,464  
Balance $ (57,291) $ (97,199) (83,521)
AOCI Attributable to Parent [Member] | Accounting Standards Update 2018-02 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]      
Balance     2,371
AOCI Attributable to Parent [Member] | Accounting Standards Update 2016-01 [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member]      
Balance     $ (27,053)
[1] Other comprehensive income related to foreign currency translation adjustments in the table above includes the amount attributable to Bio-Techne and excludes the $103 attributable to the non-controlling interest in Eminence.
[2] Gains (losses) on the interest swap will be reclassified into interest expense as payments on the derivative agreement are made. The Company reclassified $8,598 to interest expense and $512 to non-operating income relating to variable interest payments that were probable not to occur as further discussed in Note 5 for the fiscal year ended June 30, 2021. The Company also recorded a related tax benefit of $2,150 during fiscal 2021. The Company had deferred tax benefits of $1,908 and $4,058 included in the accumulated other comprehensive income loss as of June 30, 2021 and June 30, 2020, respectively.